Tango Therapeutics Inc (TNGX)
7.55
-0.24
(-3.08%)
USD |
NASDAQ |
May 17, 16:00
7.55
0.00 (0.00%)
After-Hours: 20:00
Tango Therapeutics Cash from Operations (Quarterly): -37.86M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -37.86M |
| December 31, 2023 | -27.47M |
| September 30, 2023 | -31.14M |
| June 30, 2023 | -24.47M |
| March 31, 2023 | -34.91M |
| December 31, 2022 | -28.27M |
| September 30, 2022 | -19.61M |
| Date | Value |
|---|---|
| June 30, 2022 | -31.54M |
| March 31, 2022 | -29.66M |
| December 31, 2021 | -16.90M |
| September 30, 2021 | -21.49M |
| June 30, 2021 | -7.518M |
| March 31, 2021 | -13.61M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-37.86M
Minimum
Mar 2024
-7.518M
Maximum
Jun 2021
-24.96M
Average
-27.47M
Median
Dec 2023
Cash from Operations (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | -10.38M |
| 2seventy bio Inc | -41.88M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.706M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -11.20M |
| Cash from Financing (Quarterly) | 42.98M |
| Free Cash Flow | -122.03M |
| Free Cash Flow Per Share (Quarterly) | -0.3518 |
| Free Cash Flow to Equity (Quarterly) | -38.05M |
| Free Cash Flow to Firm (Quarterly) | -38.05M |
| Free Cash Flow Yield | -16.31% |